-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

612.O1.6 612. Acute Lymphoblastic Leukemia: Clinical Studies I

Acute Lymphoblastic Leukemia: Clinical Studies Program: Oral and Poster Abstracts
Type: Oral
Saturday, December 5, 2015: 12:00 PM-1:30 PM
W230, Level 2 (Orange County Convention Center)
Moderators:
Michael J. Burke, MD, Children's Hospital of Wisconsin and Ryan D Cassaday, MD, University of Washington

Disclosures:
Cassaday: Pfizer: Research Funding ; Seattle Genetics: Research Funding .
12:00 PM

Toru Sakura1*, Fumihiko Hayakawa, MD, PhD2*, Isamu Sugiura, MD, PhD3, Kiyotoshi Imai, MD, Ph.D.4*, Noriko Usui, MD5, Shin Fujisawa, MD6*, Tohru Murayama7*, Toshiaki Yujiri, MD, PhD8, Hitoshi Kiyoi, MD, PhD2, Kazunori Ohnishi, MD, PhD9, Yasushi Miyazaki, MD10, Shigeki Ohtake, MD, PhD11, Yukio Kobayashi, MD, PhD12, Keitaro Matsuo, MD, PhD13* and Tomoki Naoe, MD, Ph.D.14

1Leukemia Research Center, Saiseikai Maebashi Hospital, Gunma, Japan
2Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
3Toyohashi Municipal Hospital, Toyohashi, Japan
4Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan
5Clinical Oncology and Hematology, The Jikei University School of Medicine, Tokyo, Japan
6Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan
7Department of Hematology, Hyogo Cancer Center, Akasi, Japan
8Third Department of Internal Medicine, Yamaguchi University School of Medicine, Yamaguchi, Japan
9Japanese Red Cross Aichi Blood Center, Seto City, Japan
10Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan
11Clinical Laboratory Science, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
12Department of Hematology, National Cancer Center Hospital, Tokyo, Japan
13Division of Moleculer Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan
14National Hospital Organization Nagoya Medical Center, Nagoya, Japan

12:15 PM

Daniel J. DeAngelo, MD, PhD1, Kristen Stevenson, MS2*, Donna S Neuberg, ScD2, Lewis B. Silverman, MD3, Karen K. Ballen, MD4, Julie D. Asch, MD5, Yasser Abou Mourad, MD6*, Kristjan Paulson, MD, FRCPC7, Matthew D. Seftel, MBChB, FRCP(C), MRCP8, David Avigan, MD9, Julie Bergeron, MD10, Stephen Couban, MD11, William Blum, MD12, John Storring, MD13, Martha Wadleigh, MD1, David P. Steensma, MD1, Jeffrey Supko, PhD4*, Stephen E. Sallan, MD14 and Richard M. Stone, MD1

1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
2Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA
3Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA
4Massachusetts General Hospital, Boston, MA
5Intermountain Blood and Marrow Transplant/Acute Leukemia Program, Salt Lake City, UT
6Vancouver General Hospital, BC Cancer Center, Vancouver, BC, Canada
7CancerCare Manitoba, Winnipeg, MB, Canada
8Department of Medical Oncology/Hematology, CancerCare Manitoba, Winnipeg, MB, Canada
9Beth Israel Deaconess Medical Center, Boston, MA
10Blood and Marrow Transplant Program and Division of Hematology, Hôpital Maisonneuve-Rosemont, Université de Montréal, Montreal, QC, Canada
11Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
12James Cancer Center, The Ohio State University, Columbus, OH
13McGill Montreal General Hospital, Montreal, QC, Canada
14Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA

12:30 PM

Sabina Chiaretti1*, Antonella Vitale1*, Loredana Elia1*, Anna Lucia Fedullo1*, Silvana Albino1*, Alfonso Piciocchi2*, Paola Fazi2*, Francesco Di Raimondo3, Antonella Fornaro4*, Francesco Fabbiano5, Alfonso Maria D'Arco6*, Giovanni Martinelli, MD, PhD7, Francesca Ronco8*, Lidia Edwige Santoro9*, Nicola Cascavilla, MD10*, Piero Galieni11*, Alessandra Tedeschi, MD12*, Simona Sica13*, Nicola Di Renzo14, Angela Melpignano15*, Angelo Michele Carella16, Felicetto Ferrara17, Marco Vignetti2* and Robin Foà1*

1Hematology, Department of Cellular Biotechnologies and Hematology, “Sapienza” University, Rome, Italy
2GIMEMA Data Center, Rome, Italy
3Department of Biomedical Sciences, Division of Hematology, Ospedale Ferrarotto, University of Catania, Italy, Catania, Italy
4Department of Hematology, Ospedale Civile dello Spirito Santo - Pescara, Pescara, Italy
5Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy, Palermo, Italy
6Division of Onco-hematology – Ospedale Umberto I - Nocera Inferiore (SA), Nocera Inferiore, Italy
7Bologna University School of Medicine, Bologna, Italy
8hematology, azienda ospedaliera bianchi-melacrino-morelli, reggio calabria, Italy
9Division of Hematology -Azienda Ospedaliera S.G.Moscati, Avellino, Italy, Avellino, Italy
10Hematology and BMT Unit, Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
11Hematology and Cellular Therapy, Ospedale Mazzoni, Ascoli Piceno, Italy
12Division of Hematology, Niguarda Ca' Granda Hospital, Milan, Italy
13Institute of Hematology, Catholic University, Rome, Italy
14Hematology, Vito Fazzi Hospital, Lecce, Italy
15Ospedale A. Perrino, Brindisi, Brindisi, Italy
16Division of Hematology 1, IRCCS A.O.U. San Martino IST, Genova, Genova, Italy
17Division of Hematology, Cardarelli Hospital, Napoli, Italy

12:45 PM

Wendy Landier, PhD, CRNP1*, Yanjun Chen, MS1*, Lindsey Hageman, MPH1*, Heeyoung Kim, MS2*, Bruce C. Bostrom, MD3, Jacqueline Casillas, M.D., M.S.H.S.4*, David Dickens, MD5*, William E. Evans, PharmD6, Kelly W. Maloney, MD7, Leo Mascarenhas, MD, MS8, Arthur K. Ritchey, MD9, Amanda M. Termuhlen, MD10*, William L. Carroll, MD11, F. Lennie Wong2*, Mary V. Relling, PharmD6 and Smita Bhatia, MD, MPH1

1Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
2Department of Population Sciences, City of Hope, Duarte, CA
3Children's Hospitals & Clinics of Minnesota, Minneapolis, MN
4Dept. of Pediatrics, Div. of Hem./Onc., Univ. of California, Los Angeles, Los Angeles, CA
5Pediatric Hematology/Oncology, Helen DeVos Children's Hospital at Spectrum Health, Grand Rapids, MI
6Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN
7Center for Cancer & Blood Disorders, Childrens Hospital Colorado, Aurora, CO
8Pediatrics, USC Keck School of Medicine at CHLA, Los Angeles, CA
9Dept. of Pediatric Hem-Onc, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA
10Jonathan Jaques Children's Cancer Center, Miller Children's and Women's Hospital Long Beach, Long Beach, CA
11Department of Pediatrics, Perlmutter Cancer Center,, New York University Medical Center, New York, NY

1:00 PM

Elias Jabbour1, Susan O'Brien, MD1, Koji Sasaki, MD2, Deborah A Thomas, MD1, Guillermo Garcia-Manero, MD1, Farhad Ravandi, MD1, Gautam Borthakur, MD1, Nitin Jain, MD1, Marina Konopleva, MD, PhD1, Jovitta Jacob, RN1*, Rebecca Garris1*, Jorge E. Cortes1 and Hagop M. Kantarjian, MD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

1:15 PM

Marketa Zaliova1, Anthony V. Moorman2, Giovanni Cazzaniga3, Martin Stanulla4*, Richard C. Harvey5, Kathryn G. Roberts6, Sue L. Heatley7*, Mignon L. Loh8, Marina Konopleva9, I-Ming Chen5, Olga Zimmermannova1*, Claire Schwab2*, Owen Smith10, Marie-Joelle Mozziconacci11*, Christian Chabannon12, Myungshin Kim13*, J.H. Frederik Falkenburg14, Alice Norton15*, Karen Marshall16*, Oskar A. Haas17, Julia Starkova1*, Jan Stuchly1*, Stephen P. Hunger18, Deborah White7*, Charles G. Mullighan6, Cheryl L Willman5, Jan Stary1, Jan Trka1 and Jan Zuna1

1CLIP- Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
2Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom
3Centro Ricerca Tettamanti, Department of Pediatrics, University of Milano-Bicocca, Fondazione MBBM/San Gerardo Hospital, Monza, Italy
4Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany
5University of New Mexico Cancer Center, Albuquerque, NM
6Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
7South Australian Health and Medical Research Institute (SAHMRI), Adelaide, Australia
8Department of Pediatrics, Hematology-Oncology, Benioff Children's Hospital, and the Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA
9Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
10Department of Haematology, Our Lady's Children's Hospital, Dublin, Ireland
11Department of Cancer Biology, Institut Paoli Calmettes, Marseille, France
12Department of Hematology, Institut Paoli Calmettes, Marseille, France
13Department of Laboratory Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea
14Department of Hematology, Leiden University Medical Center, Leiden, Netherlands
15Birmingham Children's Hospital, NHS Foundation Trust, Birmingham, United Kingdom
16Department of Cytogenetics, Leicester Royal Infirmary NHS Trust, Leicester, United Kingdom
17St. Anna Children's Hospital, Childrens Cancer Research Institute, Vienna, Austria
18Department of Pediatrics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia and the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA

*signifies non-member of ASH